Literature DB >> 25830323

Copy-number variation and false positive prenatal aneuploidy screening results.

Matthew W Snyder1, LaVone E Simmons, Jacob O Kitzman, Bradley P Coe, Jessica M Henson, Riza M Daza, Evan E Eichler, Jay Shendure, Hilary S Gammill.   

Abstract

Investigations of noninvasive prenatal screening for aneuploidy by analysis of circulating cell-free DNA (cfDNA) have shown high sensitivity and specificity in both high-risk and low-risk cohorts. However, the overall low incidence of aneuploidy limits the positive predictive value of these tests. Currently, the causes of false positive results are poorly understood. We investigated four pregnancies with discordant prenatal test results and found in two cases that maternal duplications on chromosome 18 were the likely cause of the discordant results. Modeling based on population-level copy-number variation supports the possibility that some false positive results of noninvasive prenatal screening may be attributable to large maternal copy-number variants. (Funded by the National Institutes of Health and others.).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25830323      PMCID: PMC4411081          DOI: 10.1056/NEJMoa1408408

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

1.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.

Authors:  Ghalia Ashoor; Argyro Syngelaki; Marion Wagner; Cahit Birdir; Kypros H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  2012-01-24       Impact factor: 8.661

2.  Quantification of fetal DNA by use of methylation-based DNA discrimination.

Authors:  Anders O H Nygren; Jarrod Dean; Taylor J Jensen; Selena Kruse; William Kwong; Dirk van den Boom; Mathias Ehrich
Journal:  Clin Chem       Date:  2010-08-20       Impact factor: 8.327

3.  Cell-free DNA analysis for noninvasive examination of trisomy.

Authors:  Mary E Norton; Bo Jacobsson; Geeta K Swamy; Louise C Laurent; Angela C Ranzini; Herb Brar; Mark W Tomlinson; Leonardo Pereira; Jean L Spitz; Desiree Hollemon; Howard Cuckle; Thomas J Musci; Ronald J Wapner
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

4.  Accurate description of DNA-based noninvasive prenatal screening.

Authors:  Sau W Cheung; Ankita Patel; Tak Y Leung
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

5.  Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.

Authors:  Kypros H Nicolaides; Argyro Syngelaki; Ghalia Ashoor; Cahit Birdir; Gisele Touzet
Journal:  Am J Obstet Gynecol       Date:  2012-09-19       Impact factor: 8.661

6.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.

Authors:  Rossa W K Chiu; K C Allen Chan; Yuan Gao; Virginia Y M Lau; Wenli Zheng; Tak Y Leung; Chris H F Foo; Bin Xie; Nancy B Y Tsui; Fiona M F Lun; Benny C Y Zee; Tze K Lau; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

7.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.

Authors:  H Christina Fan; Yair J Blumenfeld; Usha Chitkara; Louanne Hudgins; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-06       Impact factor: 11.205

8.  Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.

Authors:  Francesca R Grati; Francesca Malvestiti; Jose C P B Ferreira; Komal Bajaj; Elisa Gaetani; Cristina Agrati; Beatrice Grimi; Francesca Dulcetti; Anna M Ruggeri; Simona De Toffol; Federico Maggi; Ronald Wapner; Susan Gross; Giuseppe Simoni
Journal:  Genet Med       Date:  2014-02-13       Impact factor: 8.822

9.  Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

Authors:  Andrew B Sparks; Eric T Wang; Craig A Struble; Wade Barrett; Renee Stokowski; Celeste McBride; Jacob Zahn; Kevin Lee; Naiping Shen; Jigna Doshi; Michel Sun; Jill Garrison; Jay Sandler; Desiree Hollemon; Patrick Pattee; Aoy Tomita-Mitchell; Michael Mitchell; John Stuelpnagel; Ken Song; Arnold Oliphant
Journal:  Prenat Diagn       Date:  2012-01-06       Impact factor: 3.050

10.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Authors:  Glenn E Palomaki; Cosmin Deciu; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2012-02-02       Impact factor: 8.822

View more
  38 in total

1.  To NIPT or Not to NIPT.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-09-12

Review 2.  Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.

Authors:  Lisa Hui
Journal:  Obstet Med       Date:  2016-06-07

Review 3.  Prenatal and pre-implantation genetic diagnosis.

Authors:  Joris Robert Vermeesch; Thierry Voet; Koenraad Devriendt
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

4.  Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening.

Authors:  Marlise R Luskin; Marie N Discenza; Sarah Rae Easter; Paola Dal Cin; Renius Owen; Bernard Ilagan; Meredith Masiello; Andrew A Lane
Journal:  Blood Adv       Date:  2017-08-15

Review 5.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 6.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

7.  Biological explanations for discordant noninvasive prenatal test results: Preliminary data and lessons learned.

Authors:  Louise Wilkins-Haug; Chengsheng Zhang; Eliza Cerveira; Mallory Ryan; Adam Mil-Homens; Qihui Zhu; Honey Reddi; Charles Lee; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2018-05       Impact factor: 3.050

8.  Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.

Authors:  Ai-hua Yin; Chun-fang Peng; Xin Zhao; Bennett A Caughey; Jie-xia Yang; Jian Liu; Wei-wei Huang; Chang Liu; Dong-hong Luo; Hai-liang Liu; Yang-yi Chen; Jing Wu; Rui Hou; Mindy Zhang; Michael Ai; Lianghong Zheng; Rachel Q Xue; Ming-qin Mai; Fang-fang Guo; Yi-ming Qi; Dong-mei Wang; Michal Krawczyk; Daniel Zhang; Yu-nan Wang; Quan-fei Huang; Michael Karin; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

9.  Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Athena M Cherry; Yassmine M Akkari; Kimberly M Barr; Hutton M Kearney; Nancy C Rose; Sarah T South; James H Tepperberg; Jeanne M Meck
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

10.  Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.

Authors:  Andrew P Dervan; Patricia A Deverka; Julia R Trosman; Christine B Weldon; Michael P Douglas; Kathryn A Phillips
Journal:  Genet Med       Date:  2016-09-22       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.